Concepedia

Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life

Katharina M. Droege, Philipp S. Muether, Manuel M. Hermann, Albert Caramoy, Ulrike Viebahn, Bernd Kirchhof, Sascha Fauser

Graefe s Archive for Clinical and Experimental Ophthalmology · 2012 · 115 citations · 9 references

DOI

Concepts

References

9

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.9K citations · Full text

, , +12

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

David M. Brown, Peter K. Kaiser, Mark Michels et al. · New England Journal of Medicine · 2006 · 3.5K citations

, , +13

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine · 2011 · 2.6K citations · Full text

, , +12

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

Carl D. Regillo, David M. Brown, Prema Abraham et al. · American Journal of Ophthalmology · 2008 · 862 citations

, , +10

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2

Prema Abraham, Huibin Yue, Laura Wilson · American Journal of Ophthalmology · 2010 · 443 citations

, , +10